Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
BMC Nephrology|February 6, 2013
Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland ChinaJing Xu, Yi-Xiang Zhang, Xue-Qing Yu, et al.
International Journal of Rheumatic Diseases|January 3, 2014
Overview of lupus nephritis management guidelines and perspective from AsiaChi Chiu Mok, Desmond Y H Yap, Sandra V Navarra, et al.
Nephrology (Carlton, Vic.)|November 21, 2017
Addressing the burden of dialysis around the world: A summary of the roundtable discussion on dialysis economics at the First International Congress of Chinese Nephrologists 2015Philip Kam-Tao Li, Sing Leung Lui, Jack Kit-Chung Ng, et al.
Kidney Diseases (Basel, Switzerland)|February 10, 2025
Enarodustat for the Treatment of Anemia in Chinese Patients with Non-Dialysis Chronic Kidney Disease: A Phase 3 TrialXin-Ling Liang, Ren-Wei Huang, Jian-Teng Xie, et al.
Chinese Medical Journal|October 10, 2012
Current pattern of Chinese dialysis units: a cohort study in a representative sample of unitsQiu-Gen Zhou, Jian-Ping Jiang, Sheng-Jie Wu, et al.
Neurobiology of Aging|May 9, 2013
Absence of A673T amyloid-β precursor protein variant in Alzheimer's disease and other neurological diseasesSimon Kang Seng Ting, Mei-Sian Chong, Nagaendran Kandiah, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 22, 2007
Increased utilization of peritoneal dialysis to cope with mounting demand for renal replacement therapy--perspectives from Asian countriesPhilip Kam-Tao Li, Sing Leung Lui, Chi Bon Leung, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 3, 2020
[Expert consensus statement on Pudilan Xiaoyan Oral Liquid in clinical practice]Lian-Xin Wang, Qing Miao, Yan-Ming Xie, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 24, 2019
Effects of Sustained-Release Beraprost in Patients With Primary Glomerular Disease or Nephrosclerosis: CASSIOPEIR Study ResultsHidetomo Nakamoto, Xue-Qing Yu, Suhnggwon Kim, et al.
Journal of Ethnopharmacology|July 3, 2025
The efficacy and safety of Yiqi Huoxue Huatan granule in the treatment of stable COPD with chronic respiratory failure: A randomized, double-blind, placebo controlled trialJia-Yi Yang, Hong-Tao Wang, Ke-Ming Zhao, et al.
Pageof 13